# APM (Niki BioSolutions, Inc.) - SEC EDGAR Financial Statements

> Niki BioSolutions, Inc. reported $18.69M in total assets and a net loss of $1.36M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/APM
- Markdown: https://convexityos.com/fundamentals/APM.md
- SEC CIK: 0001734005
- Reporting currency: USD
- Latest filing period: December 31, 2025
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001734005&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$1.82M | Operating profit |
| Net Income | FY 2025 | -$1.36M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.19 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Dec 31, 2025 | $3.45M | Total debt: $24K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | $431K | $1.30M | $1.54M | -- | -- | -- |
| Cost of Revenue | -- | -- | $421K | $1.22M | $1.46M | -- | -- | -- |
| **Gross Profit** | -- | -- | $11K | $80K | $82K | -- | -- | -- |
| Research & Development | $353K | $2.20M | $5.20M | $9.22M | $10.87M | $11.59M | $6.94M | $3.10M |
| Total Operating Expenses | -- | -- | $31K | $18.81M | $20.75M | $21.19M | $18.73M | $10.71M |
| **Operating Income** | -$1.82M | -$3.94M | -$10.72M | -$18.72M | -$20.67M | -- | -- | -- |
| **EBITDA** | -- | -$3.69M | -$9.60M | -$17.52M | -$19.47M | -- | -- | -- |
| Interest Income | -- | -- | -- | $236K | $41K | -- | -- | -- |
| Income Before Tax | -$1.38M | -$4.16M | -$4.34M | -- | -- | -- | -- | -- |
| **Net Income** | -$1.36M | -$4.27M | -$2.82M | -$9.80M | -$25.05M | $4.92M | -$20.12M | -$14.83M |
| Basic EPS | -$0.19 | -$0.78 | -$0.62 | -$2.75 | -$7.15 | $2.03 | -$6.40 | -$5.30 |
| **Diluted EPS** | -$0.19 | -$0.78 | -$0.62 | -$2.75 | -$7.15 | $2.00 | -$6.40 | -$5.30 |
| Basic Shares Outstanding | 7.4M | 5.5M | 4.5M | 3.6M | 3.5M | 3.1M | 2.9M | 2.8M |
| Diluted Shares Outstanding | 7.4M | 5.5M | 4.5M | 3.6M | 3.5M | 3.2M | 2.9M | 2.8M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.45M | $874K | $2.01M | $1.88M | $8.13M | $3.50M | $5.19M | $12.01M | $16.25M |
| Short-Term Investments | -- | -- | -- | $102K | $237K | -- | $1.06M | $1.01M | $1.97M |
| **Cash & Short-Term Investments** | $3.45M | $874K | $2.01M | $1.99M | $8.37M | $3.50M | $6.25M | $13.02M | $18.22M |
| Accounts Receivable, Net | -- | -- | $48K | $174K | $79K | $62K | $41K | $2.8K | -- |
| Inventory | -- | -- | -- | $28K | $36K | $39K | $34K | $31K | -- |
| **Total Current Assets** | $3.59M | $960K | $2.48M | $7.07M | $12.69M | $33.66M | $8.03M | $28.72M | $20.28M |
| Property, Plant & Equipment, Net | -- | -- | $1.66M | $2.83M | $3.73M | $4.69M | $7.09M | $4.26M | $347K |
| Intangible Assets | -- | -- | $147K | $753K | $880K | $965K | $1.31M | $1.41M | $1.47M |
| Long-Term Investments | $15.10M | $15.10M | $16.10M | $9.74M | -- | -- | -- | -- | -- |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | $60K | $120K | -- |
| **Total Non-Current Assets** | $15.10M | $15.17M | $18.16M | $13.80M | $9.22M | $10.57M | $15.92M | $16.35M | $11.28M |
| **Total Assets** | $18.69M | $16.13M | $20.64M | $20.87M | $21.91M | $44.23M | $23.95M | $45.07M | $31.56M |
| **Total Current Liabilities** | $4.59M | $4.34M | $2.10M | $12.50M | $4.38M | $3.87M | $2.67M | $12.18M | $1.33M |
| Long-Term Debt | -- | -- | -- | $130K | $296K | $296K | $295K | $3.42M | $1.76M |
| **Total Non-Current Liabilities** | $306K | $14K | $3.16M | $531K | $24K | $2.21M | $6.43M | $144K | $0 |
| **Total Liabilities** | $4.90M | $4.35M | $5.26M | $13.03M | $4.40M | $6.08M | $9.10M | $12.33M | $1.33M |
| **Total Debt (incl. Leases)** | $24K | $116K | $225K | $471K | $513K | $981K | $438K | $3.60M | $1.76M |
| Common Stock | -- | -- | -- | $13.27M | $13.20M | $11.58M | -- | -- | -- |
| Retained Earnings | -$73.79M | -$72.43M | -$68.16M | -$65.34M | -$55.54M | -$30.49M | -$37.56M | -$17.38M | -$2.55M |
| Accumulated Other Comp. Income | -$92K | $89K | -$11K | $34K | -$2.0K | $53K | -$5.6K | -$1.48M | -$368K |
| **Total Stockholders' Equity** | $23.12M | $21.13M | $24.85M | $15.71M | $23.61M | $41.83M | $16.36M | $33.11M | $30.24M |
| Total Equity | $13.74M | $11.78M | $15.38M | $7.83M | $17.51M | $38.15M | $14.85M | $32.75M | $30.23M |

### Balance Sheet (Quarterly)

| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.45M | $874K | $2.01M | $1.88M | $8.13M | $3.50M | $5.19M | $12.01M |
| Short-Term Investments | -- | -- | -- | $102K | $237K | -- | $1.06M | $1.01M |
| **Cash & Short-Term Investments** | $3.45M | $874K | $2.01M | $1.99M | $8.37M | $3.50M | $6.25M | $13.02M |
| Accounts Receivable, Net | -- | -- | $48K | $174K | $79K | $62K | $41K | $2.8K |
| Inventory | -- | -- | -- | $28K | $36K | $39K | $34K | $31K |
| **Total Current Assets** | $3.59M | $960K | $2.48M | $7.07M | $12.69M | $33.66M | $8.03M | $28.72M |
| Property, Plant & Equipment, Net | -- | -- | $1.66M | $2.83M | $3.73M | $4.69M | $7.09M | $4.26M |
| Intangible Assets | -- | -- | $147K | $753K | $880K | $965K | $1.31M | $1.41M |
| Long-Term Investments | $15.10M | $15.10M | $16.10M | $9.74M | -- | -- | -- | -- |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | $60K | $120K |
| **Total Non-Current Assets** | $15.10M | $15.17M | $18.16M | $13.80M | $9.22M | $10.57M | $15.92M | $16.35M |
| **Total Assets** | $18.69M | $16.13M | $20.64M | $20.87M | $21.91M | $44.23M | $23.95M | $45.07M |
| **Total Current Liabilities** | $4.59M | $4.34M | $2.10M | $12.50M | $4.38M | $3.87M | $2.67M | $12.18M |
| Long-Term Debt | -- | -- | -- | $130K | $296K | $296K | $295K | $3.42M |
| **Total Non-Current Liabilities** | $306K | $14K | $3.16M | $531K | $24K | $2.21M | $6.43M | $144K |
| **Total Liabilities** | $4.90M | $4.35M | $5.26M | $13.03M | $4.40M | $6.08M | $9.10M | $12.33M |
| **Total Debt (incl. Leases)** | $24K | $116K | $225K | $471K | $513K | $981K | $438K | $3.60M |
| Common Stock | -- | -- | -- | $13.27M | $13.20M | $11.58M | -- | -- |
| Retained Earnings | -$73.79M | -$72.43M | -$68.16M | -$65.34M | -$55.54M | -$30.49M | -$37.56M | -$17.38M |
| Accumulated Other Comp. Income | -$92K | $89K | -$11K | $34K | -$2.0K | $53K | -$5.6K | -$1.48M |
| **Total Stockholders' Equity** | $23.12M | $21.13M | $24.85M | $15.71M | $23.61M | $41.83M | $16.36M | $33.11M |
| Total Equity | $13.74M | $11.78M | $15.38M | $7.83M | $17.51M | $38.15M | $14.85M | $32.75M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$1.38M | -$4.16M | -$4.34M | -$11.53M | -$27.11M | $4.92M | -$20.12M | -$15.13M |
| Depreciation & Amortization | -- | $255K | $1.13M | $1.21M | $1.19M | $1.33M | $1.30M | $682K |
| Stock-Based Compensation | -- | -- | $1.27M | $1.65M | $1.68M | $1.48M | $1.61M | -- |
| Change in Receivables | -- | $41K | $127K | -$96K | -$17K | -$22K | -$38K | -$2.8K |
| Change in Inventory | -- | -- | $15K | $8.1K | $3.4K | -$4.9K | -$3.5K | -$31K |
| **Operating Cash Flow** | -$1.84M | -$1.19M | -$7.72M | -$12.32M | -$14.65M | -$15.93M | -$13.38M | -$10.04M |
| Capital Expenditure | -- | -- | -$3.0K | -$187K | -$132K | -$161K | -$837K | -$5.65M |
| **Free Cash Flow** | -- | -- | -$7.73M | -$12.51M | -$14.78M | -$16.09M | -$14.22M | -$15.68M |
| Acquisitions, Net | -- | -- | -- | -- | -$114K | -- | -- | -- |
| **Investing Cash Flow** | -- | $59K | $625K | $2.44M | $16.51M | $1.84M | -$108K | -$6.06M |
| Common Stock Issued | $3.07M | -- | $1.58M | -- | $4.00M | $17.50M | -- | $11.05M |
| **Financing Cash Flow** | $4.42M | -- | $4.09M | $6.63M | $2.78M | $12.42M | -$7.32M | $25.48M |
| **Net Change in Cash** | $2.58M | -$1.13M | -$3.01M | -$3.25M | $4.64M | -$1.67M | -$20.81M | $9.38M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | 2.4% | 6.2% | 5.3% | -- | -- | -- |
| **Operating Margin** | -- | -- | -2486.0% | -1444.9% | -1340.5% | -- | -- | -- |
| **Net Profit Margin** | -- | -- | -654.8% | -756.2% | -1624.6% | -- | -- | -- |
| Return on Equity (ROE) | -5.9% | -20.2% | -11.4% | -62.4% | -106.1% | 11.8% | -123.0% | -44.8% |
| Return on Assets (ROA) | -7.3% | -26.5% | -13.7% | -47.0% | -114.3% | 11.1% | -84.0% | -32.9% |
| Current Ratio | 0.78x | 0.22x | 1.18x | 0.57x | 2.90x | 8.70x | 3.00x | 2.36x |
| Quick Ratio | 0.75x | 0.20x | 0.98x | 0.56x | 2.89x | 8.69x | 2.99x | 2.35x |
| Debt to Equity | 0.00x | 0.01x | 0.01x | 0.03x | 0.02x | 0.02x | 0.03x | 0.11x |
| **Revenue Growth (YoY)** | -- | -- | -66.7% | -15.9% | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | -- | -- | -86.8% | -2.2% | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -609.1% | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -452.2% | -- | -- | -- |
| 5Y Net Income / Share Growth | -111.7% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
